NCT00193661

Observation Study of T-Gel (1%) in Treatment of Adolescent Boys With Hypogonadism

A Multi-Center, Open-Label, Observational Study of Testosterone Gel (1%) in the Treatment of Adolescent Boys With Hypogonadism

• Status: Completed
• Phase: Phase 2
• Study type: Interventional
• Enrollment: —
• Sponsor: Solvay Pharmaceuticals · Industry
• Sex: Male
• Age: 13 Years – 17 Years
• Healthy volunteers: Not accepted

Summary

This study is to observe efficacy and safety after T-Gel 1% treatment in delayed puberty adolescents. Subjects who complete this trial may enter a 3 month extension study (UMD-01-090E).

Conditions

• Primary or Secondary Hypogonadism
• Constitutional Delay in Growth and Puberty (CDGP)

Interventions

Type	Name	Description
DRUG	Testosterone Gel (1%)

Timeline

• Start date: 2002-08-01
• Primary completion: 2007-03-01
• Completion: 2007-03-01
• First posted: 2005-09-19
• Last updated: 2015-01-16

Locations

19 sites across 1 country: United States